Date Filer Title Filing Type Shares Traded Price Total Held
Jun 14, 2023
TWOMEY CHRISTOPHER J
Director
Trans History: 14
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Jun 14, 2023
Vuori Kristiina MD
Director
Trans History: 8
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Jun 14, 2023
Wong Vincent Jung-Fai
Director
Trans History: 2
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Sep 18, 2023
Chaubey Alka
Chief Medical Officer
Trans History: 12
 Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 -- 144,794
Sep 18, 2023
Chaubey Alka
Chief Medical Officer
Trans History: 12
 Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 40,000
Sep 18, 2023
Kama Gulsen
Chief Financial Officer
Trans History: 2
 Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 106,000 -- 106,000
Sep 18, 2023
OLDAKOWSKI MARK
Chief Operating Officer
Trans History: 19
 Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 -- 317,842
Sep 18, 2023
OLDAKOWSKI MARK
Chief Operating Officer
Trans History: 19
 Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 40,000
Sep 20, 2023
Kama Gulsen
Chief Financial Officer
Trans History: 2
 Chief Financial Officer Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Feb 15, 2024
Chaubey Alka
CHIEF MEDICAL OFFICER
Trans History: 12
 CHIEF MEDICAL OFFICER Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,081 $1.27 31,487

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.